• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体膜辅因子蛋白存在于人类成纤维细胞、上皮细胞和内皮细胞上。

Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.

作者信息

McNearney T, Ballard L, Seya T, Atkinson J P

机构信息

Howard Hughes Medical Institute Laboratories, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

出版信息

J Clin Invest. 1989 Aug;84(2):538-45. doi: 10.1172/JCI114196.

DOI:10.1172/JCI114196
PMID:2474570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC548913/
Abstract

Membrane cofactor protein (MCP) of the complement system is a iC3/C3b binding molecule with cofactor activity that has been identified on all human peripheral blood cells except erythrocytes. Human mononuclear and platelet MCP is dimeric with molecular weights of 68,000 and 63,000 and is expressed in three phenotypic patterns. To further determine its tissue distribution, surface-labeled human fibroblast, epithelial, and endothelial cells and cell lines were assessed for the presence of MCP by iC3 affinity chromatography and by immunoprecipitation with a monospecific anti-MCP rabbit polyclonal antibody. All sources of adult and fetal fibroblast and epithelial cells and cell lines examined and umbilical vein endothelial cells expressed MCP. The molecular weight and phenotypic patterns of MCP were similar to those of peripheral blood cells. MCP was synthesized by fibroblast and epithelial cell lines. Solubilized extracts of these cell lines expressed factor I-dependent cofactor activity for the first cleavage of iC3/C3b which was abrogated by removal of MCP. Expression of MCP was modulated by SV40 transformation of two fetal fibroblast lines. There was a 5- to 10-fold increase in expression of MCP and a preferential expression of the lower species such that the phenotypic designation was changed. The wide tissue distribution and activity profile of MCP suggest that it is likely to play an important role in the regulation of the complement cascade.

摘要

补体系统的膜辅因子蛋白(MCP)是一种具有辅因子活性的iC3/C3b结合分子,已在除红细胞外的所有人类外周血细胞上被鉴定出来。人单核细胞和血小板MCP是二聚体,分子量分别为68,000和63,000,并以三种表型模式表达。为了进一步确定其组织分布,通过iC3亲和层析和用单特异性抗MCP兔多克隆抗体进行免疫沉淀,评估了表面标记的人成纤维细胞、上皮细胞、内皮细胞和细胞系中MCP的存在情况。所有检测的成人和胎儿成纤维细胞、上皮细胞及细胞系来源以及脐静脉内皮细胞均表达MCP。MCP的分子量和表型模式与外周血细胞相似。MCP由成纤维细胞和上皮细胞系合成。这些细胞系的可溶性提取物对iC3/C3b的首次裂解表现出I因子依赖性辅因子活性,去除MCP后该活性被消除。MCP的表达受到两个胎儿成纤维细胞系的SV40转化的调节。MCP的表达增加了5至10倍,并且低分子量物种优先表达,从而改变了表型特征。MCP广泛的组织分布和活性谱表明它可能在补体级联反应的调节中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/a6a15f7947e5/jcinvest00483-0177-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/6b2148775d40/jcinvest00483-0174-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/0fc86994bcec/jcinvest00483-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/0ecd774fd210/jcinvest00483-0175-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/2e9c311a152c/jcinvest00483-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/0d1b542ff271/jcinvest00483-0176-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/a6a15f7947e5/jcinvest00483-0177-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/6b2148775d40/jcinvest00483-0174-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/0fc86994bcec/jcinvest00483-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/0ecd774fd210/jcinvest00483-0175-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/2e9c311a152c/jcinvest00483-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/0d1b542ff271/jcinvest00483-0176-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fce/548913/a6a15f7947e5/jcinvest00483-0177-a.jpg

相似文献

1
Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.补体膜辅因子蛋白存在于人类成纤维细胞、上皮细胞和内皮细胞上。
J Clin Invest. 1989 Aug;84(2):538-45. doi: 10.1172/JCI114196.
2
Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.补体膜辅因子蛋白(MCP)的定量分析。MCP在人白血病细胞系上高表达,在细胞分化过程中表达下调。
J Immunol. 1990 Jul 1;145(1):238-45.
3
Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.衰变加速因子、膜辅因子蛋白和CD59在保护人内皮细胞免受补体介导的溶解中的相对作用。
Eur J Immunol. 1992 Dec;22(12):3135-40. doi: 10.1002/eji.1830221216.
4
Identification and characterization of membrane cofactor protein (CD46) in the human kidneys.人肾脏中膜辅因子蛋白(CD46)的鉴定与表征
Eur J Immunol. 1994 Jul;24(7):1529-35. doi: 10.1002/eji.1830240711.
5
Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes.补体膜辅助蛋白在人外周血细胞上的分布。在粒细胞上发现一种变异形式。
Eur J Immunol. 1988 Aug;18(8):1289-94. doi: 10.1002/eji.1830180821.
6
Functional properties of membrane cofactor protein of complement.补体膜辅因子蛋白的功能特性
Biochem J. 1989 Dec 1;264(2):581-8. doi: 10.1042/bj2640581.
7
Characterization of CR1- and membrane cofactor protein-like proteins of two primates.两种灵长类动物CR1及膜辅因子蛋白样蛋白的特性分析
J Immunol. 1990 Jun 1;144(11):4262-8.
8
Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.系统性硬化症患者内皮细胞中膜辅因子蛋白和衰变加速因子的异常表达。血管损伤的一种可能机制。
Lab Invest. 1994 Jun;70(6):830-5.
9
Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay.三种针对补体系统膜辅因子蛋白(MCP)的单克隆抗体的特性鉴定及通过放射分析法定量测定MCP
Clin Exp Immunol. 1991 Feb;83(2):257-61. doi: 10.1111/j.1365-2249.1991.tb05624.x.
10
C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement.C4b结合蛋白和一种60000道尔顿的血浆蛋白与补体的膜辅助蛋白共享抗原决定簇。
J Immunol. 1990 Mar 15;144(6):2312-20.

引用本文的文献

1
Chimeric Ad5/35 oncolytic adenovirus overcome preexisting neutralizing antibodies and enhance tumor targeting efficiency.嵌合型Ad5/35溶瘤腺病毒可克服预先存在的中和抗体并提高肿瘤靶向效率。
Cancer Gene Ther. 2025 Apr;32(4):418-436. doi: 10.1038/s41417-025-00884-x. Epub 2025 Mar 8.
2
Deciphering CD59: Unveiling Its Role in Immune Microenvironment and Prognostic Significance.解读CD59:揭示其在免疫微环境中的作用及预后意义
Cancers (Basel). 2024 Nov 1;16(21):3699. doi: 10.3390/cancers16213699.
3
Complement, Coagulation, and Fibrinolysis: The Role of the Endothelium and Its Glycocalyx Layer in Xenotransplantation.

本文引用的文献

1
SV40-INDUCED TRANFORMATION OF HUMAN DIPLOID CELLS: CRISIS AND RECOVERY.SV40诱导的人二倍体细胞转化:危机与恢复。
J Cell Comp Physiol. 1965 Feb;65:69-83. doi: 10.1002/jcp.1030650110.
2
Improved cell surface radioiodination of macrophages.巨噬细胞细胞表面放射性碘化的改进
J Immunol Methods. 1980;37(2):133-8. doi: 10.1016/0022-1759(80)90198-2.
3
Polymorphism of human erythrocyte C3b/C4b receptor.人类红细胞C3b/C4b受体的多态性
补体、凝血和纤溶:内皮及其糖萼层在异种移植中的作用。
Transpl Int. 2024 Oct 15;37:13473. doi: 10.3389/ti.2024.13473. eCollection 2024.
4
Viruses Binding to Host Receptors Interacts with Autophagy.病毒与宿主受体结合与自噬相互作用。
Int J Mol Sci. 2023 Feb 8;24(4):3423. doi: 10.3390/ijms24043423.
5
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35.一种完全由B型腺病毒血清型35组成的新型溶瘤腺病毒的高效抗肿瘤作用。
Mol Ther Oncolytics. 2021 Jan 26;20:399-409. doi: 10.1016/j.omto.2021.01.015. eCollection 2021 Mar 26.
6
CD46 and Oncologic Interactions: Friendly Fire against Cancer.CD46与肿瘤学相互作用:对癌症的“友军火力”
Antibodies (Basel). 2020 Nov 2;9(4):59. doi: 10.3390/antib9040059.
7
Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.病毒对补体系统的逃避及其对疫苗和治疗的重要性。
Front Immunol. 2020 Jul 9;11:1450. doi: 10.3389/fimmu.2020.01450. eCollection 2020.
8
Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation.阻断激肽释放酶-激肽系统可减少血管炎症中的内皮补体激活。
EBioMedicine. 2019 Sep;47:319-328. doi: 10.1016/j.ebiom.2019.08.020. Epub 2019 Aug 20.
9
Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration.腺病毒介导的 CD46 转导可减弱 RPE 上的替代补体途径:与年龄相关性黄斑变性的关系。
Gene Ther. 2011 Jun;18(6):613-21. doi: 10.1038/gt.2011.6. Epub 2011 Feb 10.
10
The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.副粘病毒猴病毒5型和腮腺炎病毒募集宿主细胞CD46以逃避补体介导的中和作用。
J Virol. 2009 Aug;83(15):7602-11. doi: 10.1128/JVI.00713-09. Epub 2009 May 20.
Proc Natl Acad Sci U S A. 1983 Mar;80(6):1698-702. doi: 10.1073/pnas.80.6.1698.
4
Transformation of human skeletal muscle cells by simian virus 40.猿猴病毒40对人骨骼肌细胞的转化
Proc Natl Acad Sci U S A. 1983 Nov;80(21):6581-5. doi: 10.1073/pnas.80.21.6581.
5
Transformation and immortalization of human keratinocytes by SV40.SV40介导的人角质形成细胞的转化与永生化
J Invest Dermatol. 1983 Jul;81(1 Suppl):131s-6s. doi: 10.1111/1523-1747.ep12540905.
6
Simple epithelial nature of some simian virus-40-transformed human epidermal keratinocytes.某些猿猴病毒40转化的人表皮角质形成细胞的单层上皮性质。
Cancer Res. 1984 Dec;44(12 Pt 1):5797-804.
7
The isolation of IgG from mammalian sera with the aid of caprylic acid.借助辛酸从哺乳动物血清中分离免疫球蛋白G
Arch Biochem Biophys. 1969 Nov;134(2):279-84. doi: 10.1016/0003-9861(69)90285-9.
8
Standardization of the chloramine-T method of protein iodination.蛋白质碘化氯胺-T法的标准化
Proc Soc Exp Biol Med. 1970 Mar;133(3):989-92. doi: 10.3181/00379727-133-34611.
9
Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.一种作为C3b和C4b裂解辅助因子的膜蛋白(gp45-70)的纯化与特性分析
J Exp Med. 1986 Apr 1;163(4):837-55. doi: 10.1084/jem.163.4.837.
10
Fibrin-enhanced endothelial cell organization.纤维蛋白增强内皮细胞的组织排列。
J Cell Physiol. 1985 Oct;125(1):1-9. doi: 10.1002/jcp.1041250102.